Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today ...

Ongoing Phase 1 and Phase 2 clinical programs continue to exhibit long-term durable remissions in hard-to-treat cancers, including gliob ...

Senator Hagerty’s GENIUS Act advances out of banking committee with bipartisan support despite Elizabeth Warren’s warnings ...

Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the ...

The U.S. Department of Justice and regulators will increasingly expect compliance programs to incorporate AI tools. However, ...

Governor Eli Remolona Jr. said the next big threat to the country’s defenses against dirty money could come from digital ...

The Coalition for Financial Ecosystem Standards, a fintech group co-founded by Sima Gandhi, is publishing guidelines for how ...

Riten Gohil of Signicat explains why ensuring speed, resilience and accuracy will lead to ultimate success at the 2025 UK Grand National.

The latest version of the bill expands the role of states in regulating stablecoins and proposes new transparency as well as ...

Sebi has launched a certification course focused on Anti-Money Laundering (AML) and Combating the Financing of Terrorism (CFT ...

Robinhood Markets (HOOD) stock dropped 13% in Monday morning trading as the retail trading app agreed to pay a $29.8M fine ...

Down 20% from all-time highs, TD Bank stock trades at a cheap multiple and should you deliver outsized gains in 2025 and beyond. The post Should You Buy TD Bank Stock While it’s Below $90? appeared ...